Keywords: cor, integrelin, phase, ii, results, therapeutics, usa

COR'S INTEGRELIN: PHASE II RESULTS

Article | 14 June 1993

Print This

Cor Therapeutics of the USA has presented preliminary data from a Phase II study of its platelet aggregation inhibitor, Integrelin ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in